News
Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system
2+ hour, 41+ min ago (361+ words) The pair will co-develop an off-the-shelf enhancer-media solution to boost AAV yields and "process robustness" in FUJIFILM Biosciences Balan CD HEK293 system. Virica added that it is receiving advisory services and funding from the National Research Council of Canada Industrial Research…...
Accelerating Time to Data in Cell and Gene Therapy Trials, Upcoming Webinar Hosted by Xtalks
2+ hour, 7+ min ago (169+ words) In this free webinar, gain insight into the factors impacting speed to data in CGT trials. The featured speakers will share key strategies and processes that can optimize study start-up activities and common operational bottlenecks to accelerate CGT study timelines…...
Scientists develop gene-edited wheat to make bread less carcinogenic
6+ hour, 7+ min ago (142+ words) inkl Scientists develop gene-edited wheat to make bread less carcinogenic - Scientists have developed gene-edited wheat using Crispr technology to produce bread and biscuits with significantly lower levels of acrylamide, a likely carcinogen. - The Crispr editing targets genes responsible for free…...
Around the Helix: Cell and Gene Therapy Company Updates " April 8, 2026
4+ hour, 52+ min ago (249+ words) Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies. The cell and gene therapy sectors are growing exponentially, with new players emerging daily and much progress being made both in…...
Pro QR Therapeutics Unveils New RNA Editing Programs; AX-0810 Phase 1 Target Data Due This Quarter
5+ hour, 56+ min ago (143+ words) In the Q&A, L'pez-L'pez clarified that the two-fold threshold for total bile acids would be evaluated "both compared to baseline as well as compared to placebo." Management also emphasized the trial remains double-blind and placebo-controlled, and the company has…...
CFPs: Breakthrough T1 D Small Grant Programme (United Kingdom)
8+ hour, 30+ min ago (125+ words) The Breakthrough T1 D Small Grant Programme provides funding for early career researchers in the UK to pursue innovative projects on type 1 diabetes. Grants of up to "20, 000 for basic research and "30, 000 for clinical research support exploratory studies that can inform future…...
Virica Biotech and FUJIFILM Biosciences collaborate under the Canada-Japan Co-Innovation Program to advance AAV production enhancers
10+ hour, 11+ min ago (876+ words) Virica Biotech ("Virica"), a cell enhancer company specializing in Viral Sensitizers (VSE) for viral vector manufacturing, today announced it is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), under the…...
Bio Ora and Octane Biotech sign Lo I to expand cell therapy manufacturing using Cocoon Platform
1+ day, 7+ hour ago (162+ words) Bio Spectrum Asia Bio Ora and Octane Biotech sign Lo I to expand cell therapy manufacturing using Cocoon Platform April 8, 2026 | Wednesday | News Collaboration builds on CAR-T commercialisation in New Zealand Bio Ora Limited, a commercial-stage cell therapy company advancing CAR-T…...
Frontiers | Development of in planta genome editing by transient expression of genome-editing tools in tomato
10+ hour, 19+ min ago (488+ words) Frontiers in Genome Editing Insights in Genome Editing in Plants 2024/2025 Front. Genome Ed. , 09 April 2026 Sec. Genome Editing in Plants Martina Bianca Fuhrmann-Aoyagi 1 1. Graduate School of Life and Earth Sciences, University of Tsukuba, Tsukuba, Japan Tomatoes, S. lycopersicum cultivar Sicilian Rouge was…...
CRISPR-Based Screening in Drug Discovery
20+ hour, 44+ min ago (93+ words) Synthetic lethality: finding interacting gene pairs where simultaneous disruption causes cell death, a concept commonly utilized in precision oncology. Table 1. Operational differences between pooled and arrayed CRISPR screening formats Single bulk cellular population Very high (capable of genome-wide screening) Moderate…...